Transnasal transplantation of human induced pluripotent stem cell‐derived microglia to the brain of immunocompetent mice

Transnasal transplantation of human induced pluripotent stem cell‐derived microglia to the brain of immunocompetent mice
复制标题

DOI:
10.1002/glia.23985
复制
发表时间:
2021-07
期刊:
影响因子:
6.2
通讯作者:
Bijay Parajuli;Hiroki Saito;Youichi Shinozaki;E. Shigetomi;Hiroto Miwa;Sosuke Yoneda;Miki Tanimura;S. Omachi;T. Asaki;Koji Takahashi;M. Fujita;K. Nakashima;S. Koizumi
Bijay Parajuli;Hiroki Saito;Youichi Shinozaki;E. Shigetomi;Hiroto Miwa;Sosuke Yoneda;Miki Tanimura;S. Omachi;T. Asaki;Koji Takahashi;M. Fujita;K. Nakashima;S. Koizumi
中科院分区:
医学1区
文献类型:
--
作者:
Bijay Parajuli;Hiroki Saito;Youichi Shinozaki;E. Shigetomi;Hiroto Miwa;Sosuke Yoneda;Miki Tanimura;S. Omachi;T. Asaki;Koji Takahashi;M. Fujita;K. Nakashima;S. Koizumi

文献摘要

相似文献

小胶质细胞是大脑中的常驻免疫细胞,在神经元发育、稳态功能和神经退行性疾病中发挥重要作用。人类小胶质细胞与小鼠小胶质细胞相对不同。然而,大多数关于人类小胶质细胞的研究都是在体外进行的,这并不能准确地代表体内条件下小胶质细胞的特征。为了阐明人小胶质细胞的体内特征,已经开发了产生诱导的多能或胚胎干细胞衍生的人小胶质细胞并将其移植到新生或成年小鼠脑中的方法。然而,它的广泛使用仍然受到产生人类小胶质细胞的技术困难以及需要使用免疫缺陷小鼠和进行侵入性手术的限制。为了解决这些问题,我们开发了一种简化的方法来产生诱导多能干细胞衍生的人小胶质细胞,并将其通过免疫活性小鼠的经鼻途径移植到大脑中,并与集落刺激因子1受体拮抗剂组合。我们发现,当给予外源性人细胞因子时,人小胶质细胞能够通过筛板迁移到大脑的不同区域,增殖,并通过占据空龛以区域特异性方式成为主导性小胶质细胞,持续至少60天。
Microglia are the resident immune cells of the brain, and play essential roles in neuronal development, homeostatic function, and neurodegenerative disease. Human microglia are relatively different from mouse microglia. However, most research on human microglia is performed in vitro, which does not accurately represent microglia characteristics under in vivo conditions. To elucidate the in vivo characteristics of human microglia, methods have been developed to generate and transplant induced pluripotent or embryonic stem cell‐derived human microglia into neonatal or adult mouse brains. However, its widespread use remains limited by the technical difficulties of generating human microglia, as well as the need to use immune‐deficient mice and conduct invasive surgeries. To address these issues, we developed a simplified method to generate induced pluripotent stem cell‐derived human microglia and transplant them into the brain via a transnasal route in immunocompetent mice, in combination with a colony stimulating factor 1 receptor antagonist. We found that human microglia were able to migrate through the cribriform plate to different regions of the brain, proliferate, and become the dominant microglia in a region‐specific manner by occupying the vacant niche when exogenous human cytokine is administered, for at least 60 days.